Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Recruiting 8Active not recruiting 6Completed 4Unknown 3Terminated 3Withdrawn 1

Sponsor Class

OTHER 7OTHER_GOV 1

Study Type

Observational 5Interventional 3

Sponsor

Cancer Type

Genitourinary 8

Conditions

Prostatic Neoplasms 8Glioma 3Breast Neoplasms 3Brain Neoplasms 3Thyroid Neoplasms 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Neoplasms 1Thyroid Nodule 1Thrombocythemia, Essential 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Primary Myelofibrosis 1Precancerous Conditions 1Polycythemia Vera 1

Interventions

Magnetic Resonance Spectroscopy 51Specimen Handling 42enzalutamide 35Androgen Antagonists 34Radiosurgery 32Radiotherapy 31Prednisone 26darolutamide 24Abiraterone Acetate 24Leuprolide 22Docetaxel 22apalutamide 20Pluvicto 19abiraterone 18Standard of Care 18Triptorelin Pamoate 17Radiation 17Biopsy 16relugolix 15acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Goserelin 14Blood Specimen Collection 13gallium 68 PSMA-11 12pembrolizumab 11X-Rays 11Surveys and Questionnaires 11luprolide acetate gel depot 10Carboplatin 10Methods 9Interviews as Topic 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Recruiting × Prostatic Neoplasms × Watchful Waiting × Clear all
NCT00949819 2026-05-26

ASCaP

Jonsson Comprehensive Cancer Center

Recruiting
462 enrolled
Genitourinary

Prostatic Neoplasms

NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Roswell Park Cancer Institute

Phase 4 Recruiting
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT06378866 2026-04-20

DIVINE

Mayo Clinic

Phase 2 Recruiting
532 enrolled
Genitourinary

Prostatic Neoplasms

NCT05840484 2026-02-19

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

M.D. Anderson Cancer Center

Recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT05810467 2026-02-04

AS

Institute of Cancer Research, United Kingdom

Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT06200103 2025-09-11

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Mayo Clinic

Phase 2 Recruiting
236 enrolled
Genitourinary

Prostatic Neoplasms

NCT05940415 2024-01-31

ASWBP

Anhui Provincial Hospital

Recruiting
220 enrolled
Genitourinary

Prostatic Neoplasms

NCT02971085 2019-02-12

SUPER-PC-AS

Seoul National University Hospital

Recruiting
410 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡